满￥6666，赠豪华版黑神话悟空
Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 /
抑制剂/激动剂
酶学 肿瘤
/
酶制剂
免疫/炎症 酶抑制剂 肿瘤发展和微环境演变
/
环氧合酶抑制剂
环氧化酶 环氧合酶
/ Celecoxib

塞来昔布 /Celecoxib 98%

货号：A180379 同义名： 塞来西布 / SC 58635;YM-177 Ambeed 开学季，买赠积分，赢豪礼

Celecoxib is a selective COX-2 inhibitor with IC50 of 40 nM.

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Celecoxib 化学结构 CAS号：169590-42-5
Celecoxib 化学结构
CAS号：169590-42-5
Celecoxib 3D分子结构
CAS号：169590-42-5
Celecoxib 化学结构 CAS号：169590-42-5
Celecoxib 3D分子结构 CAS号：169590-42-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Celecoxib 纯度/质量文件 产品仅供科研

货号：A180379 标准纯度： 98%
批次查询： 批次纯度:

全球学术期刊中引用的产品

• Cell,2024. Ambeed. [ A125712 ]
• Cancer Discov., 2024. Ambeed. [ A285925 ]
• JMC, 2024, 67(17): 14974-14985. Ambeed. [ A288696 ]
• JMC, 2024, 67(17): 15061-15079. Ambeed. [ A524399 , A633512 , A144280 , A174613 ]
• EJNMMI Radiopharm. Chem., 2024, 9, 61. Ambeed. [ A1257961 , A622068 ]
更多 >
产品名称 COX ↓ COX-1 ↓ COX-2 ↓ 其他靶点 纯度
Piroxicam ✔ 98%
Salicylic acid ✔ 98%
Phenacetin ✔ 98%
Etodolac ✔ 99%
Flunixin meglumine ✔ 98%
Ibuprofen L-lysine ✔ 99%
Nabumetone ✔ 98%
Acemetacin ✔ 98%
Diflunisal ✔ 98%
Pranoprofen ✔ 98%
Ampiroxicam ✔ 98%
Meloxicam ✔ 98%
Sulindac ✔ 98%
Ketoprofen ✔ 98%
Mefenamic Acid ✔ 95%
Bromfenac sodium ✔ 98%
Oxaprozin ✔ 99%
Aspirin ✔ 99%
Nepafenac ✔ 98%
Zaltoprofen ✔ 99%
Salicin ✔ 98%
Suprofen ✔ 99%+
Xanthohumol ✔ 99%
Parecoxib ✔ 98%
Tolfenamic Acid +++

COX-2, IC50: 0.2 μM

 		98%
Etoricoxib ✔ 99%
Niflumic Acid ✔ 98%
Valdecoxib ++++

COX-2, IC50: 5 nM

 		99+%
Ibuprofen +

COX-1, IC50: 13 μM

 		+

COX-2, IC50: 370 μM

 		98%
Indomethacin ++

COX1, IC50: 0.28 μM

 		+

COX-2, IC50: 14 μM

 		97%
Lornoxicam ++++

COX-1, IC50: 5 nM

 		++++

COX-2, IC50: 8 nM

 		98%
Meclofenamic acid sodium ++++

COX-1, IC50: 40 nM

 		+++

COX-2, IC50: 50 nM

 		99%
Rofecoxib ++++

COX-2, IC50: 18 nM

 		98%
Asaraldehyde ✔ 98%
Naproxen +

COX-1, IC50: 8.7 μM

 		+

COX-2, IC50: 5.2 μM

 		98%
Diclofenac Sodium Salt +++

COX-1, IC50: 60 nM

 		+++

COX-2, IC50: 200 nM

 		98%
NS-398 ++

COX-2, IC50: 3.8 μM

 		98%
Amfenac Sodium Hydrate ++

COX-1, IC50: 250 nM

 		+++

COX-2, IC50: 150 nM

 		98%+
Nimesulide +

COX-2, IC50: 26 μM

 		98%
Lumiracoxib ++

COX-1, Ki: 3 μM

 		+++

COX-2, Ki: 60 nM

 		98%
Rutaecarpine ✔ 95%
Celecoxib ++++

COX-2, IC50: 40 nM

 		98%
Carprofen ++++

canine COX2, IC50: 30 nM

 		98%
Ketorolac ++

COX-1 (human), IC50: 1.23 μM

 		++

COX-2 (human), IC50: 3.50 μM

 		98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Celecoxib 生物活性

靶点

  • COX-2

    COX-2, IC50:40 nM
描述 Cyclooxygenase (COX) is an enzyme that produces precursors to prostaglandins and thromboxanes. It is associated with rheumatoid arthritis (RA), osteoarthritis (OA), and other inflammatory disorders. Celecoxib is a dyaryl heterocyclic inhibitor of COX-2, a subtype of COX that is highly expressed in inflamed tissues. In human dermal fibroblasts, celecoxib inhibited COX-2-mediated production of prostaglandin E2 (PGE2) with an IC50 at 91 nM, compared to its IC50 value of COX-1 inhibition at 2800 nM[6]. When IL-1β-stimulated fibroblast-like synoviocytes were treated by 10 μM celecoxib for 24 hours, the production of PGE2 and the gene expression of COX-2 were significantly decreased compared to non-treated cells[7]. In vivo, celecoxib was orally administrated to male Sprague-Dawley rats 4 hours after carrageenan injection, and it was shown to abrogate carrageenan-induced thermal hyperalgesia with an ED30 value of 0.81 mg/kg. Celecoxib also showed inhibitory effect on lipopolysaccharide-induced pyrexia in rats with an ED30 of 1.3 mg/kg[6]. RA patients who received 40, 200, or 400 mg celecoxib twice daily for 4 weeks presented significantly reduced signs and symptoms[8]. In OA patients, 6-week treatment of 200 mg celecoxib once daily significantly improved their scores on pain satisfaction scales[9].
作用机制 The phenylsulfonamide moiety of celecoxib binds to the side pocket of cyclooxygenase (COX)-2 to prevent the activation of COX-2 to other stimuli[8].

Celecoxib 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
201T Growth Inhibition Assay 72 h IC50=48.6 µM 25057941
273T Growth Inhibition Assay 72 h IC50=80.5 µM 25057941
A2780 5/10/15 μM Function Assay 48 h decreases Cox-2 expression in a dose-dependent manner 25424898
A2780 5/10/15 μM Function Assay 48 h elevates the expression of E-cadherin and keratin 25424898

Celecoxib 动物研究

Dose Rat: 10 mg/kg - 50 mg/kg[3] (p.o.) Dog: 7.5 mg/kg - 25 mg/kg[4] (p.o.)
Administration p.o.
Pharmacokinetics
Animal Rats[5]
Dose 10 mg/kg
Administration p.o./i.v.
F 64.5% (p.o.)
Vd 1860 ml/kg (i.v.)
T1/2 3.67 h (p.o.)
3.49 h (i.v.)
Tmax 3 h (p.o.)
Cmax 2.01 μg/ml (p.o.)
4.87 μg/ml (i.v..)
AUC0→∞ 18.5 μg·h/ml (p.o.)
28.7 μg·h/ml (i.v.)

Celecoxib 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00653250 Lung Cancer Not Applicable Completed - -
NCT00533247 Postoperative Pain Not Applicable Unknown - Canada, British Columbia ... 展开 >> Not yet recruiting Vancouver, British Columbia, Canada Contact: Adam Zanbilowicz, BA DPM MS    604-885-8803    zanbilowicz@pol.net 收起 <<
NCT00153660 Arthritis Car... 展开 >>diovascular Diseases Cerebrovascular Disorders 收起 << Phase 3 Completed - China, Hong Kong ... 展开 >> Endoscopy Center, Prince of Wales Hospital Shatin, Hong Kong, China 收起 <<

Celecoxib 参考文献

[1]Safaeian L, Hajhashemi V, et al. The effect of celecoxib on blood pressure and plasma oxidant/antioxidant status in co-administration with glucocorticoid in rat. Biomed Pharmacother. 2018 Dec;108:1804-1808.

[2]Paulson SK, Vaughn MB, et al. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. J Pharmacol Exp Ther. 2001 May;297(2):638-45.

[3]CELEBREX

[4]55(7):394-402.

[5]42(6):499-506.

[6]Yoshino T, Kimoto A, Kobayashi S, Noguchi M, Fukunaga M, Hayashi A, Miyata K, Sasamata M. Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor. Arzneimittelforschung. 2005;55(7):394-402.

[7]Kawashima M, Ogura N, Akutsu M, Ito K, Kondoh T. The anti-inflammatory effect of cyclooxygenase inhibitors in fibroblast-like synoviocytes from the human temporomandibular joint results from the suppression of PGE2 production. J Oral Pathol Med. 2013 Jul;42(6):499-506.

Celecoxib 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.62mL

0.52mL

0.26mL

13.11mL

2.62mL

1.31mL

26.22mL

5.24mL

2.62mL

Celecoxib 技术信息

CAS号169590-42-5
分子式C17H14F3N3O2S
分子量 381.37
别名 塞来西布 ;SC 58635;YM-177;Celebrex
运输蓝冰
存储条件

粉末 Keep in dark place,Inert atmosphere,Room temperature

液体 -20°C:3-6个月-80°C:12个月
溶解度

DMSO: 50 mg/mL(131.11 mM)，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO
动物实验配方

2% DMSO+30% PEG 300+5% Tween 80+water 5 mg/mL

Tags: Celecoxib | 169590-42-5 | SC 58635 | SC58635 | SC-58635 | COX-2inhibitor | Immunology/Inflammation | COX | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Celecoxib 纯度/质量文件 | Celecoxib 亚型比较 | Celecoxib 生物活性 | Celecoxib 细胞研究 | Celecoxib 动物研究 | Celecoxib 临床数据 | Celecoxib 参考文献 | Celecoxib 实验方案 | Celecoxib 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z